Skip to content
Triangle logo TriangleGet started
← Kaposi Sarcoma

HEALTH PROFESSIONAL · SOURCE READING

Imatinib

Source: Kaposi Sarcoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 7, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of AIDS-Associated Kaposi Sarcoma / Treatment Options for AIDS-Associated Kaposi Sarcoma / Biological and targeted therapy

Imatinib is a c-kit/platelet-derived growth factor receptor inhibitor.

Evidence (imatinib):

A phase II trial included 30 patients with AIDS-associated KS.[20]

Source links and citations

A phase II trial included 30 patients with AIDS-associated KS.[20]

A partial response (PR) was seen in 10 of 30 previously treated patients . Previous treatment included antiretroviral therapy and chemotherapy.

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice